SCHEMBL7773014

SCHEMBL7773014

Nc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)n[nH]c2C(F)(F)F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.61
CA12 O43570 3/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA9 Q16790 3/20 0.49
CA14 Q9ULX7 3/20 0.49
MAP2K7 O14733 1/20 0.46
MAP2K4 P45985 1/20 0.46
PTGS1 P23219 2/20 0.45
PTGS2 P35354 2/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
AGO2 Q9UKV8 1/20 0.45
CA5B Q9Y2D0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7773326 0.90 LRRK2 (0.68) LRRK2CA12CA1CA2CA9
SCHEMBL7779654 0.88 LRRK2 (0.60) LRRK2CA12CA1CA2CA9
SCHEMBL7779954 0.88 LRRK2 (0.60) LRRK2CA12CA1CA2CA9
SCHEMBL7773215 0.88 LRRK2 (0.77) LRRK2CA1CA2MAP2K7MAP2K4
SCHEMBL7779939 0.88 LRRK2 (0.52) LRRK2PTGS2GYS1L3MBTL1
SCHEMBL7777620 0.88 LRRK2 (0.60) LRRK2CA12CA1CA2CA9
SCHEMBL7777308 0.85 LRRK2 (0.57) LRRK2MAP2K7MAP2K4PTGS1PTGS2
SCHEMBL7778058 0.85 MAPT (0.58) LRRK2CA12CA1CA2CA9
SCHEMBL7779735 0.85 LRRK2 (0.57) LRRK2CA12CA1CA2CA9
SCHEMBL7777625 0.85 LRRK2 (0.57) LRRK2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed